ONE YEAR FOLLOW-UP RESULTS FROM PRESERVE-AMI: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED CLINICAL TRIAL OF INTRACORONARY INFUSION OF AUTOLOGOUS CD34+ CELLS IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION POST STEMI

Autor:	Candice Junge, Ali E. Denktas, Stephen Frohwein, Anna Maria Kanakaraj, Robert A. Preti, Charles J. Davidson, Gregory W. Barsness, Ahmed Abdel-Latif, Timothy D. Henry, Alejandro Vasquez, Andrew L. Pecora, Dean J. Kereiakes, David M. Shavelle, Vitaly Druker, Martin H. Cohen, Nabil Dib, Marc Klapholz, Gary L. Schaer, Douglas W. Losordo, Richard A. Schatz, Thomas J. Moss, Catalin Toma, Le Dich, Pamela Hyde, Arshed A. Quyyumi
Rok vydání:	2015
Předmět:	medicine.medical_specialty One year follow up business.industry medicine.medical_treatment medicine.disease Revascularization Placebo Surgery Clinical trial Double blind surgical procedures operative Heart failure Internal medicine medicine Cardiology ST segment cardiovascular diseases Myocardial infarction Cardiology and Cardiovascular Medicine business
Zdroj:	Journal of the American College of Cardiology. 65:A1593
ISSN:	0735-1097
Popis:	ST segment Elevation Myocardial Infarction (STEMI) affects 160,000 annually in the US. Guidelines direct immediate revascularization and adjunctive medical therapies. Yet STEMI victims remain at risk for infarct expansion, heart failure, reinfarction, repeat revascularization and death. In pre
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa00743390b2106d8731d02a7528705 https://doi.org/10.1016/s0735-1097(15)61593-5 Zobrazit plný text záznamu